Correlation Between Foghorn Therapeutics and Nurix Therapeutics
Can any of the company-specific risk be diversified away by investing in both Foghorn Therapeutics and Nurix Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Foghorn Therapeutics and Nurix Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Foghorn Therapeutics and Nurix Therapeutics, you can compare the effects of market volatilities on Foghorn Therapeutics and Nurix Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Foghorn Therapeutics with a short position of Nurix Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Foghorn Therapeutics and Nurix Therapeutics.
Diversification Opportunities for Foghorn Therapeutics and Nurix Therapeutics
0.88 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Foghorn and Nurix is 0.88. Overlapping area represents the amount of risk that can be diversified away by holding Foghorn Therapeutics and Nurix Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nurix Therapeutics and Foghorn Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Foghorn Therapeutics are associated (or correlated) with Nurix Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nurix Therapeutics has no effect on the direction of Foghorn Therapeutics i.e., Foghorn Therapeutics and Nurix Therapeutics go up and down completely randomly.
Pair Corralation between Foghorn Therapeutics and Nurix Therapeutics
Given the investment horizon of 90 days Foghorn Therapeutics is expected to under-perform the Nurix Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Foghorn Therapeutics is 1.01 times less risky than Nurix Therapeutics. The stock trades about -0.2 of its potential returns per unit of risk. The Nurix Therapeutics is currently generating about -0.05 of returns per unit of risk over similar time horizon. If you would invest 2,004 in Nurix Therapeutics on October 20, 2024 and sell it today you would lose (90.00) from holding Nurix Therapeutics or give up 4.49% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Foghorn Therapeutics vs. Nurix Therapeutics
Performance |
| Timeline |
| Foghorn Therapeutics |
| Nurix Therapeutics |
Foghorn Therapeutics and Nurix Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Foghorn Therapeutics and Nurix Therapeutics
The main advantage of trading using opposite Foghorn Therapeutics and Nurix Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Foghorn Therapeutics position performs unexpectedly, Nurix Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nurix Therapeutics will offset losses from the drop in Nurix Therapeutics' long position.| Foghorn Therapeutics vs. C4 Therapeutics | Foghorn Therapeutics vs. Prelude Therapeutics | Foghorn Therapeutics vs. Rezolute | Foghorn Therapeutics vs. Shattuck Labs |
| Nurix Therapeutics vs. Foghorn Therapeutics | Nurix Therapeutics vs. Shattuck Labs | Nurix Therapeutics vs. Monte Rosa Therapeutics | Nurix Therapeutics vs. Kymera Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |